Cite

HARVARD Citation

    Hernández, D. et al. (2014). A1.26 Establishing cut-off of infliximab levels and anti-infliximab antibodies by commercial elisa in patients with rheumatoid arthritis. Annals of the rheumatic diseases. p. A11. [Online]. 
  
Back to record